DePuy Synthes Receives 510(k) FDA Clearance for VELYS ™ Robotic-Assisted Solution Designed for Use with the ATTUNE® Total Knee System

PALM BEACH GARDENS, FL., January 19, 2021 – Today, The Johnson & Johnson Medical Devices Companies* announced that DePuy Synthes** has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the VELYS™ Robotic-Assisted Solution designed for use with the ATTUNE® Total Knee System and its cleared indications for use. It will become part of the broader VELYS Digital Surgery Platform of connected technologies. With a growing and aging patient population, demand for joint replacement surgery is increasing. But across the industry, data shows up to 20% of knee replacement patients aren’t satisfied with the outcome of their surgery.[1],[2] Technology advancements that help surgeons address pain, function and alignment could help facilitate a positive improvement in quality of life for patients.[3] The VELYS Robotic-Assisted Solution is a first-of-its-kind table mounted solution, with an efficient design that integrates into any OR. The system adapts to the surgeon’s workflow, and is designed to give them the control they are used to and helps them execute accurate bony cuts.[4] It utilizes advanced planning capabilities, proprietary technology and a next-generation design to help surgeons to accurately resect bones that align and position the implant relative to the soft-tissue during total knee replacement without the need for pre-operative imaging.It simplifies knee replacement surgery by providing the following benefits: · Valuable Insights: G...
Source: Johnson and Johnson - Category: Pharmaceuticals Tags: Our Company Source Type: news